Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis
- 1 October 2019
- Vol. 37 (44) , 6588-6593
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
This publication has 18 references indexed in Scilit:
- Effect of the Deletion of Genes Encoding Proteins of the Extracellular Virion Form of Vaccinia Virus on Vaccine Immunogenicity and Protective Effectiveness in the Mouse ModelPLOS ONE, 2013
- Failure of the Smallpox Vaccine To Develop a Skin Lesion in Vaccinia Virus-Naïve Individuals Is Related to Differences in Antibody Profiles before Vaccination, Not AfterClinical and Vaccine Immunology, 2012
- Serological responses in humans to the smallpox vaccine LC16m8Journal of General Virology, 2011
- Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive AdultsThe Journal of Infectious Diseases, 2011
- Smallpox vaccines: targets of protective immunityImmunological Reviews, 2010
- Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox VaccineJournal of Virology, 2008
- Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine Modified Vaccinia Virus Ankara Is Comparable to That of DryvaxJournal of Virology, 2008
- Proteome‐wide analysis of the serological response to vaccinia and smallpoxProteomics, 2007
- LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from MonkeypoxJournal of Virology, 2006
- Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challengeVaccine, 2006